Identification of organic contaminants in leachates from industrial waste landfillsBENFENATI, E; FACCHINI, G; PIERUCCI, P et al.TrAC. Trends in analytical chemistry (Regular ed.). 1996, Vol 15, Num 8, pp 305-310, issn 0165-9936Article

SULLA PROBABILE ATTIVITA 1ALPHA ,25-DIIDROSSICOLECALCIFEROLO DEL SOLANUM MALACOXYLON ESSICCATO, ASSUNTO CON L'ALIMENTAZIONE. = SUR L'ACTIVITE PROBABLE DE 1ALPHA ,25 DIHYDROXYCHOLECALCIFEROL DU SOLANUM MALACOXYLON SECHE ABSORBE AVEC LES ALIMENTSBOROZZINO G; FACCHINI G; MARANESI M et al.1977; BOLL. SOC. ITAL. BIOL. SPER.; ITAL.; DA. 1977; VOL. 53; NO 22; PP. 2129-2132; BIBL. 7 REF.Article

Third order optical characterisation of a π-conjugated polydiacetylene by Maker fringes techniqueD'AMORE, F; ZAPPETTINI, A; FACCHINI, G et al.Synthetic metals. 2002, Vol 127, Num 1-3, pp 143-146, issn 0379-6779Conference Paper

Congestion models and weighted Bayesian potential gamesFACCHINI, G; VAN MEGEN, F; BORM, P et al.Theory and decision. 1997, Vol 42, Num 2, pp 193-206, issn 0040-5833Article

Phase I study of vinorelbine and paclitaxel in small-cell lung cancerIAFFAIOLI, R. V; FACCHINI, G; TORTORIELLO, A et al.Cancer chemotherapy and pharmacology. 1997, Vol 41, Num 1, pp 86-90, issn 0344-5704Article

Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trialsNASTI, G; OTTAIANO, A; ROMANO, G et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 2, pp 209-218, issn 0344-5704, 10 p.Article

Molecular and preclinical models enhancing anti-tumour activity of zoledronic acidMARRA, M; SANTINI, D; CARAGLIA, M et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 79-85, issn 1359-6349, 7 p.Conference Paper

Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancerTORTORIELLO, A; FACCHINI, G; CAPONIGRO, F et al.Breast cancer research and treatment. 1998, Vol 47, Num 1, pp 91-97, issn 0167-6806Article

Accelerated split-course (type B) thoracic radiation therapy plus vinorelbine/carboplatin combination chemotherapy in stage III inoperable non-small cell lung cancerIAFFAIOLI, R. V; CAPONIGRO, F; TORTORIELLO, A et al.European journal of cancer (1990). 1996, Vol 32, Num 11, pp 1901-1904, issn 0959-8049Article

A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancerIAFFAIOLI, R. V; TORTORIELLO, A; ANTONELLI, B et al.British journal of cancer. 1995, Vol 72, Num 5, pp 1256-1258, issn 0007-0920Article

Follow-up of bone mineral density and body composition in adolescents with restrictive anorexia nervosa: role of dual-energy X-ray absorptiometryFRANZONI, E; CICCARESE, F; DI PIETRO, E et al.European journal of clinical nutrition. 2014, Vol 68, Num 2, pp 247-252, issn 0954-3007, 6 p.Article

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancerLAFFAIOLI, R. V; TORTORIELLO, A; FERRANTE, G et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 921-926, issn 0732-183XArticle

Rudist facies distribution in the Central-Southern Apennines and Apulia, ItalyLAVIANO, A; SIRNA, G; FACCHINI, G et al.Géobios. Mémoire spécial. 1998, Num 2, pp 169-180, issn 0293-843XConference Paper

Phase II study of high-dose epirubicin, lonidamine, alpha 2b interferon in advanced breast cancerIAFFAIOLI, R. V; TORTORIELLO, A; FACCHINI, G et al.Breast cancer research and treatment. 1995, Vol 35, Num 3, pp 243-248, issn 0167-6806Article

Carboplatin and α-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot studyFRASCI, G; TORTORIELLO, A; FACCHINI, G et al.European journal of cancer. Part A. 1994, Vol 30, Num 7, pp 946-950Article

Synthesis and use of pentadeuteroethyl ethofumesate as an internal standard for the determination of ethofumesate and its metabolites in water by gas chromatography-mass spectrometryTERRENI, M; BENFENATI, E; NATANGELO, M et al.Journal of chromatography. A. 1994, Vol 688, Num 1-2, pp 243-250Article

Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-α2b in ovarian cancer patients with minimal residual diseaseFRASCI, G; TORTORIELLO, A; FACCHINI, G et al.Gynecologic oncology (Print). 1993, Vol 50, Num 1, pp 60-67, issn 0090-8258Article